Kunal Rayakar

Kunal Rayakar is an Associate at RA Capital Management in Boston, MA, where he works within the TechAtlas division. In this role, he focuses on biotechnology and healthcare investments, contributing to research, due diligence, and strategy for identifying promising therapeutics and technology assets. His responsibilities leverage both scientific and financial expertise to support the firm's activity across the life sciences sector.

Prior to joining RA Capital, Kunal held a position specializing in healthcare and biotechnology investing at Monashee Investment Management LLC, where he conducted research and analysis on innovative therapeutics and biotech companies. He also gained previous experience as an intern at RA Capital, further deepening his insight into venture and public markets within life sciences.

Kunal holds degrees from MIT Sloan School of Management, the University of California, Berkeley, and Rice University. His background combines advanced training in finance and science, equipping him to critically evaluate opportunities within biotechnology, medical technology, and health sciences, with a particular focus on identifying novel and high-impact therapeutic platforms.